Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC

PURPOSE: Adjuvant chemotherapy with cisplatin (CDDP) plus vinorelbine is the standard regimen for the treatment of non-small cell lung cancer (NSCLC). However, CDDP elicits severe toxic effects, including emesis, neurotoxicity, and renal damage; carboplatin (CBDCA) may be a feasible alternative for...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Manag Res
Egile Nagusiak: Katsurada, Naoko, Tachihara, Motoko, Hatakeyama, Yukihisa, Koyama, Kiyoko, Yumura, Masako, Kiriu, Tatsunori, Dokuni, Ryota, Hazama, Daisuke, Tokunaga, Shuntaro, Tamura, Daisuke, Nakata, Kyosuke, Yamamoto, Masatsugu, Kamiryo, Hiroshi, Kobayashi, Kazuyuki, Tanaka, Yugo, Maniwa, Yoshimasa, Nishimura, Yoshihiro
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove 2020
Gaiak:
Clinical Trial Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7007497/
https://ncbi.nlm.nih.gov/pubmed/32099473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S239647
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak